Indication
Latent Tuberculosis Infection
3 clinical trials
4 products
Product
Mycobacterium VaccaeClinical trial
Phase IV Clinical Trial of the Safety, Efficacy, and Immunogenicity of Mycobacterium Vaccae for Injection (Mica) in People Over 15 Years of Age With Latent Mycobacterium Tuberculosis InfectionStatus: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
Comparing Incidence Rate of Systemic Drug Reactions Under 3HP and 1HP Regimen for Latent Tuberculosis Infection Treatment: a Pragmatic Multicenter Randomized Control TrialStatus: Completed, Estimated PCD: 2023-10-08
Product
Isoniazid and RifapentineClinical trial
Screening for Latent Tuberculosis Infection (LTBI) in US Army RecruitsStatus: Completed, Estimated PCD: 2009-06-01
Product
BSTProduct
TST